Literature DB >> 23055182

Patient-centered or 'central' patient: Raising the veil of ignorance over randomization.

Anirban Basu1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23055182      PMCID： PMC4283500          DOI： 10.1002/sim.5398

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  16 in total

1.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

2.  Medicaid's prior authorization program and access to atypical antipsychotic medications.

Authors:  Jennifer M Polinski; Philip S Wang; Michael A Fischer
Journal:  Health Aff (Millwood)       Date:  2007 May-Jun       Impact factor: 6.301

3.  Who can respond to treatment? Identifying patient characteristics related to heterogeneity of treatment effects.

Authors:  Sherrie H Kaplan; John Billimek; Dara H Sorkin; Quyen Ngo-Metzger; Sheldon Greenfield
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

4.  Individualization at the heart of comparative effectiveness research: the time for i-CER has come.

Authors:  Anirban Basu
Journal:  Med Decis Making       Date:  2009 Nov-Dec       Impact factor: 2.583

5.  Who should determine when health care is medically necessary?

Authors:  S Rosenbaum; D M Frankford; B Moore; P Borzi
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

6.  Commentary: How the debate about comparative effectiveness research should impact the future of clinical trials.

Authors:  Michael S Lauer
Journal:  Stat Med       Date:  2012-11-10       Impact factor: 2.373

7.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

8.  Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.

Authors:  J E Richter; P J Kahrilas; J Johanson; P Maton; J R Breiter; C Hwang; V Marino; B Hamelin; J G Levine
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

9.  Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change.

Authors:  Stephen B Soumerai; Fang Zhang; Dennis Ross-Degnan; Daniel E Ball; Robert F LeCates; Michael R Law; Tom E Hughes; Daniel Chapman; Alyce S Adams
Journal:  Health Aff (Millwood)       Date:  2008-04-01       Impact factor: 6.301

10.  Predicting the brain response to treatment using a Bayesian hierarchical model with application to a study of schizophrenia.

Authors:  Ying Guo; F DuBois Bowman; Clinton Kilts
Journal:  Hum Brain Mapp       Date:  2008-09       Impact factor: 5.038
View more
  1 in total

1.  Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai; Richard F MacLehose; Faye L Norby; Rob F Walker; Nicholas S Roetker; Terrence J Adam; Alvaro Alonso
Journal:  Br J Haematol       Date:  2019-03-28       Impact factor: 6.998
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.